SCHEMBL2010304

SCHEMBL2010304

Cc1[c]cccc1-c1ccccc1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 6/20 0.41
HSD17B10 Q99714 5/20 0.41
ALDH1A1 P00352 4/20 0.41
BCL2L1 Q07817 1/20 0.41
SMN1; SMN2 Q16637 5/20 0.37
MAPT P10636 4/20 0.36
NFKB1 P19838 3/20 0.36
RAB9A P51151 3/20 0.36
KDM4E B2RXH2 3/20 0.36
NPC1 O15118 2/20 0.36
CYP3A4 P08684 2/20 0.36
ALOX15 P16050 2/20 0.36
RECQL P46063 2/20 0.36
CA12 O43570 1/20 0.36
GMNN O75496 1/20 0.36
EGFR P00533 1/20 0.36
CA2 P00918 1/20 0.36
LMNA P02545 1/20 0.36
FYN P06241 1/20 0.36
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22115865 0.84
SCHEMBL314757 0.80
SCHEMBL6762310 0.78 ALDH1A1 (0.44) HPGDHSD17B10ALDH1A1BCL2L1SMN1; SMN2
SCHEMBL100932 0.78 TSHR (0.39) HPGDALDH1A1SMN1; SMN2RAB9ANPC1
SCHEMBL10767657 0.77 SMN1; SMN2 (0.43) HPGDHSD17B10ALDH1A1BCL2L1SMN1; SMN2
SCHEMBL2015542 0.75 ACHE (0.39) ALDH1A1SMN1; SMN2NFKB1RAB9AKDM4E
SCHEMBL6852286 0.75 KMT2A (0.43) HPGDALDH1A1SMN1; SMN2MAPTRAB9A
SCHEMBL7959773 0.75 TP53 (0.41) HPGDHSD17B10ALDH1A1BCL2L1SMN1; SMN2
SCHEMBL695988 0.74 PDCD1 (0.39) HPGDHSD17B10ALDH1A1BCL2L1SMN1; SMN2
SCHEMBL2373478 0.74 SMN1; SMN2 (0.46) HPGDHSD17B10ALDH1A1BCL2L1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7960571-B2 Silicon-based cross-coupling reagent and production method of organic compound using the same KYOTO UNIVERSITY (JP) 2011-06-14 US disclosed
US-20090069577-A1 Silicon-Based Cross-Coupling Reagent and Production Method of Organic Compound Using the Same KYOTO UNIVERSITY (JP) 2009-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069577-A1 Silicon-Based Cross-Coupling Reagent and Production Method of Organic Compound Using the Same DNMT1, TET3, CTCF HPGD 4481/4885HSD17B10 3287/4885ALDH1A1 3368/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.